Cargando…

Machine learning application for classification of Alzheimer's disease stages using (18)F-flortaucipir positron emission tomography

BACKGROUND: The progression of Alzheimer’s dementia (AD) can be classified into three stages: cognitive unimpairment (CU), mild cognitive impairment (MCI), and AD. The purpose of this study was to implement a machine learning (ML) framework for AD stage classification using the standard uptake value...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Sang Won, Yeo, Na Young, Lee, Jinsu, Lee, Suk-Hee, Byun, Junghyun, Park, Dong Young, Yum, Sujin, Kim, Jung-Kyeom, Byeon, Gihwan, Kim, Yeshin, Jang, Jae-Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149022/ https://www.ncbi.nlm.nih.gov/pubmed/37120537 http://dx.doi.org/10.1186/s12938-023-01107-w

Ejemplares similares

Deep learning application for the classification of Alzheimer’s disease using (18)F-flortaucipir (AV-1451) tau positron emission tomography
por: Park, Sang Won, et al.
Publicado: (2023)

Head-to-head comparison of tau positron emission tomography tracers [(18)F]flortaucipir and [(18)F]RO948
por: Smith, Ruben, et al.
Publicado: (2019)

Predicting progression to dementia with “comprehensive visual rating scale” and machine learning algorithms
por: Park, Chaeyoon, et al.
Publicado: (2022)

Influence of Sensory Impairments on Incidence of Dementia in the Korean Population
por: Oh, Gyu han, et al.
Publicado: (2023)

Dementia Incidence Rate Before and After Implementing the National Responsibility Policy for Dementia Care in Patients With Vascular Risk Factors in Korea
por: Byeon, Gihwan, et al.
Publicado: (2023)

Parametric methods for [(18)F]flortaucipir PET
por: Golla, Sandeep SV, et al.
Publicado: (2018)

F-18 fluorodeoxyglucose positron emission tomography for differential diagnosis and prognosis prediction of vascular tumors
por: Lee, Won Woo, et al.
Publicado: (2017)

Analysis of (18)F-Fluorodeoxyglucose and (18)F-Fluoride Positron Emission Tomography in Korean Stroke Patients with Carotid Atherosclerosis
por: Kim, Jeong-Min, et al.
Publicado: (2019)

The role of (18)F-fluorodeoxyglucose-positron emission tomography/computed tomography in the differential diagnosis of pericardial disease
por: Hyeon, Cheol Won, et al.
Publicado: (2020)

The Role of Preoperative (18)F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Retroperitoneal Sarcoma
por: Jo, Sung Jun, et al.
Publicado: (2022)

(18)F-Flortaucipir in TDP-43 associated frontotemporal dementia
por: Smith, R., et al.
Publicado: (2019)

Emerging role of (18)F-fluorodeoxyglucose positron emission tomography for guiding management of hepatocellular carcinoma
por: Lee, Sang Mi, et al.
Publicado: (2019)

F-18 Sodium Fluoride Positron Emission Tomography/Computed Tomography for Detection of Thyroid Cancer Bone Metastasis Compared with Bone Scintigraphy
por: Lee, Hyunjong, et al.
Publicado: (2016)

The Role of 18F-Flortaucipir (AV-1451) in the Diagnosis of Neurodegenerative Disorders
por: Roy, Saswata, et al.
Publicado: (2021)

(18)F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes
por: Tsai, Richard M., et al.
Publicado: (2019)

Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Management of Cervical Dystonia
por: Lee, Han Byul, et al.
Publicado: (2012)

In vivo imaging of invasive aspergillosis with (18)F-fluorodeoxysorbitol positron emission tomography
por: Kim, Dong-Yeon, et al.
Publicado: (2022)

Pulmonary artery intimal sarcoma: poor (18)F-fluorodeoxyglucose uptake in positron emission computed tomography
por: Lee, Dong-Hyup, et al.
Publicado: (2013)

Radiomics Features of (18)F-Fluorodeoxyglucose Positron-Emission Tomography as a Novel Prognostic Signature in Colorectal Cancer
por: Kang, Jeonghyun, et al.
Publicado: (2021)

Analysis of (18)F-fluorodeoxyglucose positron emission tomography findings in patients with pituitary lesions
por: Seok, Hannah, et al.
Publicado: (2013)

Evaluation of a visual interpretation method for tau‐PET with (18)F‐flortaucipir
por: Sonni, Ida, et al.
Publicado: (2020)

Effect of Shortening the Scan Duration on Quantitative Accuracy of [(18)F]Flortaucipir Studies
por: Tuncel, Hayel, et al.
Publicado: (2021)

Unsupervised [(18)F]Flortaucipir cutoffs for tau positivity and staging in Alzheimer’s disease
por: Quattrini, Giulia, et al.
Publicado: (2023)

Pulmonary actinomycosis mimicking lung cancer on positron emission tomography
por: Choi, Hayoung, et al.
Publicado: (2017)

Cost-effectiveness of using amyloid positron emission tomography in individuals with mild cognitive impairment
por: Lee, Young-Sil, et al.
Publicado: (2021)

Neural Signature for Auditory Hallucinations in Schizophrenia: A High-Resolution Positron Emission Tomography Study with Fludeoxyglucose ((18)F)
por: Kim, Jong-Hoon, et al.
Publicado: (2018)

In Vivo (18)F-Flortaucipir PET Does Not Accurately Support the Staging of Progressive Supranuclear Palsy
por: Malpetti, Maura, et al.
Publicado: (2022)

Maximum standardized uptake value on (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improves outcome prediction in retroperitoneal liposarcoma
por: Rhu, Jinsoo, et al.
Publicado: (2019)

Prediction Model for Tumor Budding Status Using the Radiomic Features of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Cervical Cancer
por: Chong, Gun Oh, et al.
Publicado: (2021)

Does (18)F-FDG Positron Emission Tomography-Computed Tomography Have a Role in Initial Staging of Hepatocellular Carcinoma?
por: Cho, Yuri, et al.
Publicado: (2014)

Improved detection of metastatic lymph nodes in oesophageal squamous cell carcinoma by combined interpretation of fluorine-18-fluorodeoxyglucose positron-emission tomography/computed tomography
por: Lee, Ji Young, et al.
Publicado: (2019)

Prognostic value of intratumoral metabolic heterogeneity on F-18 fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced cervical cancer patients treated with concurrent chemoradiotherapy
por: Chong, Gun Oh, et al.
Publicado: (2017)

THK5351 and flortaucipir PET with pathological correlation in a Creutzfeldt-Jakob disease patient: a case report
por: Kim, Hee Jin, et al.
Publicado: (2019)

[(18)F]Flortaucipir PET Across Various MAPT Mutations in Presymptomatic and Symptomatic Carriers
por: Wolters, Emma E., et al.
Publicado: (2021)

Association of the top 20 Alzheimer's disease risk genes with [(18)F]flortaucipir PET
por: Stage, Eddie, et al.
Publicado: (2022)

Monoamine oxidase binding not expected to significantly affect [(18)F]flortaucipir PET interpretation
por: Wright, Justin P., et al.
Publicado: (2022)

Diagnostic Performance of (18)F-Fluorodeoxyglucose Positron Emission Tomography/CT for Chronic Empyema-Associated Malignancy
por: Cheon, Miju, et al.
Publicado: (2019)

Prognostic Value of (18)F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Resectable Pancreatic Cancer
por: Choi, Hye Jin, et al.
Publicado: (2013)

Analysis of treatment pattern of anti-dementia medications in newly diagnosed Alzheimer’s dementia using OMOP CDM
por: Byun, JungHyun, et al.
Publicado: (2022)

(11)C-acetate and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization
por: Park, Sohyun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ljv2o6ipborgp9cju1ma077bfm